BOBA:CRYPTOCAPMarket Cap BOBA, $ Analysis
Data as of 2026-05-18 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
PT Formosa Ingredient Factory (BOBA.JK) is trading at IDR 276, well above its DCF‑derived fair value of roughly IDR 77, indicating a significant premium (PE 16.3, PB 1.83). The stock sits comfortably above its 20‑day SMA (268.55) and 50‑day SMA (206.66), supporting a bullish price bias, yet the MACD histogram is negative and the signal line is bearish, suggesting short‑term momentum weakness. RSI at 56 shows the shares are not overbought, while volume trends are decreasing, which could limit upside in the near term. Volatility is extremely high at ~181% over 30 days, and the computed beta of –0.47 points to an inverse correlation with the broader market, adding a unique risk‑return profile. Fundamentally, the company posted 27.7% revenue growth, solid gross (33.7%) and operating margins (17.9%), and generates strong cash flow (operating cash flow IDR 28.8 bn). ROE of 11.9% and a dividend yield of 2.54% underscore decent profitability and shareholder return, though the payout ratio is effectively zero, raising questions about dividend sustainability. Debt levels are modest (debt‑to‑equity 0.35) and cash balances are healthy, providing a cushion against market stress. The consumer‑defensive packaged‑foods sector offers stability, but regulatory and geographic exposures in Indonesia remain material considerations. Overall, the stock appears overvalued relative to fundamentals, but its defensive positioning and cash generation make it attractive for longer horizons if price corrections occur.
Market Outlook
Short Term
< 1 yearKey Factors
- bearish MACD histogram
- decreasing trading volume
- price above short‑term moving averages but near resistance
Medium Term
1–3 yearsKey Factors
- robust revenue growth (27.7%)
- strong cash generation and low leverage
- defensive consumer sector with stable demand
Long Term
> 3 yearsKey Factors
- sustainable dividend yield (2.54%)
- solid ROE and ROA
- negative beta offering market hedge
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.